- ARS Pharmaceuticals (SPRY) appointed Donn Casale as chief executive officer and director, effective July 7, 2026, succeeding co-founder Richard Lowenthal.
- Richard Lowenthal stepped down as an employee and officer of the company, effective July 6, 2026.
- Casale previously served as president
